摘要
Mitochondria are crucial in sustaining and orchestrating cellular functions.Capitalizing on this,we explored mitochondrial transplantation as an innovative therapeutic strategy for acute spinal cord injury(SCI).In our study,we developed an engineered mitochondrial compound tailored to target macrophages within the SCI region.Sourced from IL-10-induced Mertkhi bone marrow-derived macrophages,we conjugated a peptide sequence,cations-cysteine-alanine-glutamine-lysine(CAQK),with the mitochondria,optimizing its targeting affinity for the injury site.Our data demonstrated that these compounds significantly enhanced macrophage phagocytosis of myelin debris,curtailed lipid buildup,ameliorated mitochondrial dysfunction,and attenuated pro-inflammatory profiles in macrophages,both in vitro and in vivo.The intravenously delivered mitochondrial compounds targeted the SCI epicenter,with macrophages being the primary recipients.Critically,they promoted tissue regeneration and bolstered functional recovery in SCI mice.This study heralds a transformative approach to mitochondrial transplantation in SCI,spotlighting the modulation of macrophage activity,phagocytosis,and phenotype.
基金
supported by the Key Program of the National Natural Science Foundation of China(No.82030071)
the National Natural Science Foundation of China(No.82202722,No.81874004)
the Science and Technology Major Project of Changsha(No.kh2103008)
the Science Foundation of Xiangya Hospital for Young Scholar(Grant No.2021q18)
the Natural Science Foundation of Changsha city(Grant No.kq2202378)
Graduate students of Central South University independently explore innovative projects(2022ZZTS094).
